Monday, March 10, 2014
With the opening of the Global Center for Health Innovation in October 2013, this installment of Cleveland Connects will examine the biotech business and its economic development ramifications in the greater Cleveland area. What already sets Northeast Ohio apart? How best can we build on Cleveland's considerable biotech assets and how can we best attract new talent and investment capital to the region? How can the greater community profit from the innovations already seeded by the Cleveland Clinic, Case Medical Center, the Austen BioInnovation Institute in Akron and the MetroHealth System, to name just a few? We will seek out answers to these and many other questions on the next Cleveland Connects.
Keynote Speaker: David Johnson, CEO and President of Indiana's BioCrossroads. BioCrossroads is a catalyst for life sciences ideas. Whether it’s providing funding, launching new businesses, or partnering with Indiana’s research institutions, global companies, philanthropic organizations and government, BioCrossroads mission is to advance Indiana’s next generation of growth and innovation.
Moderator, Mike McIntyre, host of The Sound of Ideas, ideastream’s daily public affairs talk show which airs from 9:00-10:00 a.m. on 90.3 WCPN and Tipoff columnist for The Plain Dealer and cleveland.com.
Rebecca Bagley, President & CEO, NorTech. NorTech is a technology-based economic development organization working to revitalize Northeast Ohio by accelerating the growth of innovation clusters in advanced energy, flexible electronics and water technologies.
Baiju Shah, CEO, BioMotive. BioMotiv is the mission-driven accelerator associated with The Harrington Project for Discovery & Development, a national initiative centered at University Hospitals Case Medical Center in Cleveland. The company’s focus is accelerating breakthrough discoveries from research institutions into therapeutics for patients.
Dr. Frank L. Douglas, President and CEO of Austen BioInnovation Institute in Akron. The Austen BioInnovation Institute in Akron - a collaboration of Akron Children’s Hospital, Akron General Health System, Northeast Ohio Medical University, Summa Health System, The University of Akron and The John S. and James L. Knight Foundation - is focused on patient-centered innovation and commercialization at the intersection of biomaterials and medicine.
Dr. Daniel Simon, Division Chief, Cardiovascular Medicine, University Hospitals Case Medical Center and Director, Harrington Heart and Vascular Institute, University Hospitals.
Dr. Thomas Graham, Chief Innovations Officer, Cleveland Clinic Innovations. CCI delivers the critical mass needed to bring ground-breaking medical innovations to market and are recognized as a leader in healthcare corporate venturing.